题名 | 5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study |
作者 | |
通讯作者 | Wu, Wenyu; Tang, Yang; Li, Hang |
发表日期 | 2024-06-20
|
DOI | |
发表期刊 | |
ISSN | 0366-6999
|
EISSN | 2542-5641
|
卷号 | 137期号:12 |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 其他
|
WOS研究方向 | General & Internal Medicine
|
WOS类目 | Medicine, General & Internal
|
WOS记录号 | WOS:001250895900011
|
出版者 | |
ESI学科分类 | CLINICAL MEDICINE
|
来源库 | Web of Science
|
引用统计 | |
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/786561 |
专题 | 南方科技大学第一附属医院 |
作者单位 | 1.Peking Univ First Hosp, Natl Clin Res Ctr Skin & Immune Dis, Dept Dermatol & Venerol, Beijing Key Lab Mol Diag Dermatoses, Beijing 100034, Peoples R China 2.Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200040, Peoples R China 3.Kunming Med Univ, Affiliated Hosp 1, Kunming 650032, Yunnan, Peoples R China 4.Wuhan 1 Hosp, Dept Dermatol, Wuhan 430022, Hubei, Peoples R China 5.Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou 510630, Guangdong, Peoples R China 6.Sichuan Univ, West China Hosp, Dept Dermatol, Chengdu 610044, Sichuan, Peoples R China 7.Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Guangzhou, Peoples R China 8.Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen 518020, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 |
Ran, Menglong,Wu, Wenyu,Tang, Yang,et al. 5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study[J]. CHINESE MEDICAL JOURNAL,2024,137(12).
|
APA |
Ran, Menglong.,Wu, Wenyu.,Tang, Yang.,Zhang, Liang.,Wan, Miaojian.,...&Li, Hang.(2024).5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study.CHINESE MEDICAL JOURNAL,137(12).
|
MLA |
Ran, Menglong,et al."5-Aminolaevulinic acid-based photodynamic therapy for actinic keratosis in Chinese patients: A prospective multicenter study".CHINESE MEDICAL JOURNAL 137.12(2024).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论